Xenetic Biosciences Inc Stock, NASDAQ:XBIO
945 Concord Street, Suite 102, Framingham, Massachusetts 01701
United States of America
Number of Employees: 4
Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patientÃ¢â?¬â?¢s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.